Background: Malignant melanoma is an aggressive tumor defined by some histopathologic variables which dictate its behavior and vary in different populations. To date, no data exist on these histopathologic characteristics in Ethiopian Patients.
Objective: To describe histopathologic features of primary cutaneous melanoma in Ethiopian patients.
Method: In an attempt to define these features, histologic slides and patient record forms of cases diagnosed as primary cutaneous malignant melanoma were retrieved from records of the Pathology Department of Tikur Anbessa Specialized Teaching Hospital. From the patient records demographic variables including age, sex and anatomic location were documented. The histologic slides were revised for pathologic parameters like, histologic type, depth of invasion, host lymphocytic infiltration and pigmentation.
Results: A total of 50 cases of primary cutaneous malignant melanoma were diagnosed in the period of 1999-2005 in Tikur Anbesa Hospital, pathology department. There were equal numbers of male and female patients; the mean age was 51.6 years. Most of the melanomas (64%) were located on the foot. The vast majority (96%) of the cases were nodular melanomas while there was one case of acral lentiginous melanoma and another case of superficial spreading melanoma. Seven (14%) were nonpigmented melanomas. The prognosis was poor with 72% of the cases showing Clark level V invasion and mean Breslow tumor thickness of 6.02mm. Ulceration was present in the majority (83.3%) of the cases.
Conclusion: Melanoma in Ethiopian patients is characterized by late stage presentation associated with poor prognosis and high preponderance to the foot. The higher prevalence of nodular melanomas with deep vertical invasion support the argument that this type might be a result of progression of other forms as most of our cases were late stage melanomas.
Download full-text PDF |
Source |
---|
Clin Cosmet Investig Dermatol
January 2025
Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Lymphomatoid papulosis (LyP) is currently categorized as a primary lymphoproliferative disorder that follows a chronic, recurrent clinical course. The diagnosis of LyP is mainly based on clinical presentation and histopathological correlation. Six subtypes of LyP have been described and recognized, each with different histological features and sometimes distinct clinical presentations.
View Article and Find Full Text PDFJID Innov
March 2025
Department of Dermatology, University Hospital of Zurich, University of Zurich, Schlieren, Switzerland.
In cutaneous melanoma, epigenetic dysregulation is implicated in drug resistance and tumor immune escape. However, the epigenetic mechanisms that influence immune escape remain poorly understood. To elucidate how epigenetic dysregulation alters the expression of surface proteins that may be involved in drug targeting and immune escape, we performed a 3-dimensional surfaceome screen in primary melanoma cultures and identified the DNA-methyltransferase inhibitor decitabine as significantly upregulating the costimulatory molecule ICAM-1.
View Article and Find Full Text PDFExp Dermatol
January 2025
Department of Dermatology, Kansai Medical University, Hirakata, Osaka, Japan.
Chronic inflammation in the tumour microenvironment (TME) via Th2-polarisation promotes melanoma progression and metastasis, making it a target for immunotherapy. Interleukin (IL)-4 is considered essential for Th2-polarisation in the TME; however, its source remains unknown. Basophils have been postulated as one of its sources.
View Article and Find Full Text PDFJ Am Acad Dermatol
January 2025
Department of Dermatology, Columbia University Irving Medical Center, New York, NY. Electronic address:
Introduction: Dermatomyositis (DM) is an uncommon idiopathic inflammatory myopathy resulting in characteristic patterns of cutaneous lesions and myositis. Observational evidence related to the disease is limited by small case cohorts. We aimed to evaluate the validity of specialist-specific diagnostic coding for DM in an outpatient clinical database.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!